TCM
EVGN icon

Tradewinds Capital Management’s Evogene EVGN Stock Holding History

Tradewinds Capital Management’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$101 Hold
131
– – ﹤0.01% 684
2025
Q4 		$145 Sell
131
-169
-56% -$197 ﹤0.01% 644
2025
Q3 		$343 Hold
300
– – ﹤0.01% 623
2025
Q2 		$384 Buy
+300
New +$367 ﹤0.01% 568

Other funds holding EVGN

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Tradewinds Capital Management's EVGN Position: Q1 2026 in Review

Tradewinds Capital Management held its Evogene (EVGN) position steady in Q1 2026 at 131 shares worth $101. The position accounts for ﹤0.01% of the portfolio, ranked #684.

Tradewinds Capital Management first reported a position in EVGN in Q2 2025 and has held it in 4 quarters since. The position peaked at $384 in Q2 2025. 15 funds tracked by Wall St. Rank hold EVGN as of Q1 2026.

  • Tradewinds Capital Management held 131 shares of Evogene worth $101 as of Q1 2026.
  • Tradewinds Capital Management left its Evogene share count unchanged in Q1 2026.
  • Evogene made up ﹤0.01% of Tradewinds Capital Management's portfolio in Q1 2026, its #684 holding.
  • Tradewinds Capital Management first reported a position in Evogene in Q2 2025 and has held it in 4 quarters since.
  • Tradewinds Capital Management's Evogene position peaked at $384 in Q2 2025.
  • 15 funds tracked by Wall St. Rank held Evogene as of Q1 2026.

Based on Tradewinds Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.